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Edited by Jesus AvilaAbstract We identiﬁed a novel gene and named it, ‘‘neuronal
development-associated protein (NDAP)’’. We detected NDAP
mRNA presence in most tissues including the brain where it
was present in the area from the external granular layer to the
multiform layer in the cerebral cortex, and in CA1, CA2, CA3
and the dentate gyrus in the hippocampus. Its expression in-
creased transiently in primary cultures of 2–4 day neurons and
1–2 week astrocytes and was signiﬁcantly reduced in older cul-
tures. Treatment by the neurotrophin, NT-3, signiﬁcantly atten-
uated the decline of NDAP in neurons from days 2 to 10,
whereas growth factors such as GDNF and insulin, and high
potassium levels did not. To elucidate the eﬀects of neurotro-
phins, we treated day 5 neurons with NT-3, BDNF or NGF
for 48 h. NT-3 and BDNF both inhibited downregulation of
NDAP mRNA levels but NGF slightly enhanced the already
present downregulation; this eﬀect of NGF was signiﬁcant when
examined in day 3 neurons. To investigate the potential function
of NDAP, we over-expressed an NDAP-EGFP fusion protein in
4-week-old astrocytes. The newly expressed NDAP gradually
aggregated into membrane-bound structures and eventually led
to cell death through apoptosis by 24 h. Signiﬁcant levels of cell
death were also observed in NDAP-EGFP transfected HEK293
cells. Thus maintenance of high NDAP levels may cause apopto-
sis. The diﬀerent regulations of NDAP expression by neurotro-
phins indicate that the expression of NDAP might be a
checkpoint for apoptosis during neuronal development.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Highly conserved and genetically encoded events are respon-
sible for precisely manipulated developmental programs. The
switching on and oﬀ of certain genes in a predetermined manner
early in embryogenesis ensures appropriate neuronal subtype
survival and diﬀerentiation [1]. Diﬀerential gene expression dur-
ing development, together with the temporal expression and*Corresponding author. Fax: +86 10 82805066.
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doi:10.1016/j.febslet.2006.02.022modulation of growth factors, especially neurotrophins, deter-
mine a neuronal fate of maturation or apoptosis [2–4].
Our previous studies demonstrated that neurons in primary
cultures prepared from E16 mouse brain cortices become func-
tionally mature between days 4 and 7 [5,6]. RAP-PCR, a
means to discover diﬀerentially regulated genes, was used to
identify diﬀerentially expressed mRNA transcripts in these
cerebral cortical neurons at various ages (2, 4, 7, and 10
days-old) [6,7]. Among them, we identiﬁed one mRNA tran-
script, which decreased in level from days 4 to 7. We named
this novel gene and protein, ‘‘neuronal development-associated
protein (NDAP)’’. By screening a cDNA library, the full-
length sequence of NDAP was identiﬁed and submitted to
GenBank as Ndap7 gene (GenBank accession number:
AJ308886). From genomic BLAST, the NDAP gene was
found to be located on mouse chromosome 2 and the protein
product was comprised of 578 amino acids. GenBank database
searches showed that NDAP shared a conserved domain with
Saccharomyces cerevisiae Gpi16 protein and Homo sapiens
PIG-T protein. These two proteins belong to the transamidase
family and are responsible for transferring a glycosylphosphat-
idylinositol (GPI) tail to newly synthesized proteins [8].
We are interested in the potential role of NDAP in nerve cell
development. In this study, we report that the expression of
NDAP was regulated by neurotrophins. Cells over-expressing
NDAP died of apoptosis, implicating NDAP expression as a
potential checkpoint for cell apoptosis during early develop-
ment.2. Materials and methods
2.1. Primary cultures and growth factor treatments
Primary cultures of cerebral cortical neurons and astrocytes were
prepared from ICR mice as described by Li et al. [6] and Chen et al.
[9], respectively. All growth factors except potassium chloride were
purchased from Invitrogen (USA). Potassium chloride was purchased
from Sigma (USA).
2.2. RAP-PCR, cloning and cDNA library screening
mRNA was isolated from neurons on diﬀerent days (2, 4, 7, and 10)
using the QuickPrep Micro mRNA Puriﬁcation System (Pharmacia
Biotech, Sweden). RAP-PCR was performed as described by Li et al.
[6]. Screening of newborn mouse brain cDNA library in k ZAP II
(Stratagene, USA) was performed according to the manufacturer’s
instructions. Primers designed to amplify the ORF of full-length
NDAP were used to isolate the full-length cDNA from the cDNA
pool.blished by Elsevier B.V. All rights reserved.
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Adult mouse brain was ﬁxed in 4% paraformaldehyde at 4 C over-
night. Cryosections of 16 lm were prepared for in situ hybridization.
The sectionswere immersed inhybridizationbuﬀer [50%deionized form-
amide, 1· Denhardt’s solution, 4· SSC, 10 mM DTT, 1 mg/ml yeast
tRNA, 100 ng/ml digoxigenin (DIG)-labelled antisense cRNAprobe (la-
beled using aDIG labeling kit fromRoche, Germany)] at 55 C for 12 h.
After the sections had been washed in 4· SSC and 0.1· SSC, they were
incubated in a primary antibody solution (diln 1:2000) containing anti-
DIG antibody-alkaline phosphatase conjugate at room temperature
overnight. Color development was carried out using Chrimagen Solu-
tion (Roche, Germany), followed by serial dehydration with 50–100%
alcohol. The sections were permanently mounted in neutral balsam, ob-
served under an optical microscope and stored at room temperature.
2.4. RT-PCR
Total RNA was prepared by TRIzol reagent (Invitrogen, USA)
according to the manufacturer’s instructions. RT-PCR was carried out
according to Li et al. [6]. The sequences of primers were: GAPDH-for-
ward, 5 0-TGATGACATCAAGAAGGTGGTGAAG-30; GAPDH-re-
verse, 5 0-TCCTTGGAGGCCATGTAGGCCAT-3 0; NDAP-forward,
5 0-AGAGCTCTGGGTCTGGTTCCAAGA-3 0; NDAP-reverse, 5 0-
GCAGGGAGTAGTCGTCAGTGTC-3 0. PCR conditions were:
94 C for 3 min, followed by 29 cycles of 94 C for 45 s, 59 C for 45 s,
and72 Cfor 1 min; anda ﬁnal extensionat 72 Cfor 10 min. PCRprod-
uctswere separatedon2%agarose gels andband intensitywas quantiﬁed
by TotalLab2.0 (Nonlinear, UK).
2.5. Transient transfection of astrocytes and HEK293 cells
pLNCX2-NDAP-EGFP and pLNCX2-EGFP expression vectors
were created from pLNCX2 and pEGFP-N1 (Clontech, USA). The
full-length coding sequence of NDAP was inserted upstream of EGFP.
Transient transfections were performed with Lipofectamine2000
(Invitrogen, USA) [9]. Nuclei of astrocytes were stained with Hoechst
33342 (2 lg/ml).
Over-expression of NDAP-EGFP caused cell shrinkage and detach-
ment. To assay cell death in detached HEK 293 cells 48 h after trans-
fection, cells in the medium were collected by centrifugation atFig. 1. (A) Localization of NDAP mRNA in mouse cerebral cortex by in situ
cRNA probe. High expression of NDAP mRNA was observed in the neuro
Arrows indicate the lower boundary of layer II (external granular layer) and
(molecular layer). (b) No positive signal could be detected by the sense probe
expression of NDAP mRNA transcripts was observed in the neurons in Am
signal could be detected by the sense probe. Bar = 200 lm. (C) mRNA expre
the cortex, cerebellum, spinal cord, heart, liver, intestine, kidney and muscle. T
as internal control.1000 rpm for 5 min. The cells were re-plated in poly-D-lysine coated
dishes for 12 h. To distinguish dead cells from living cells, the re-plated
cells were stained without ﬁxation with propidium idodide (PI) instead
of Hoechst 33342. Dead cells exhibit red ﬂuorescence. Cell death rate
was calculated as the percentage of dead cells (red) among the transfec-
ted (green).
2.6. Statistical analysis
Experiments were repeated a minimum of three times. Statistical
analyses were performed using one-way ANOVA with the post hoc
Newman–Keuls test for multiple comparisons and two-way ANOVA
with the Bonferroni post tests using PRISM4.0 (GraphPad Software,
Inc., USA).3. Results and discussion
Primary cultures of mouse cerebral cortical neurons of 2, 4,
7, and 10 days were adopted for diﬀerential gene expression
studies. A diﬀerentially expressed cDNA transcript was discov-
ered by RAP-PCR and three clones with overlapping se-
quences were subsequently isolated from a newborn mouse
brain cDNA library. Their assembled sequence was 3.5 kb
and contained an open reading frame of 1.737 kb. This was
then directly cloned from the cDNA pool and named, ‘‘neuro-
nal development-associated protein (NDAP)’’.
In situ hybridization showed that NDAP mRNA transcripts
in the adult mouse brain had speciﬁc distributions in the cere-
bral cortex and hippocampus. NDAP mRNA expression was
more evident in the area from the external granular layer to
the multiform layer in the cortex (Fig. 1Aa, arrows indicate
the lower boundary of external granular and ganglionic layers)
and in CA1, CA2, CA3 and the dentate gyrus (DG) in the hip-
pocampus (Fig. 1Ba). No signal was observed in layer Ihybridization. (a) NDAP mRNA transcripts were detected by antisense
ns of layer II (external granular layer) to layer VI (multiform layer).
layer V (ganglionic layer). No positive signal was detected in the layer I
. Bar = 200 lm. (B) In situ hybridization in the hippocampus. (a) High
mon’s horn (CA1, CA2 and CA3) and the dentate gyrus (DG). (b) No
ssion of NDAP in various tissues. NDAP was detected by RT-PCR in
race levels of NDAP were found in lung and pancreas. GAPDH served
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lack of cell bodies in this layer. Sense probes served as negative
controls (Fig. 1Ab and Bb). RT-PCR showed NDAP presence
additionally in the spinal cord, heart, liver, intestine, kidney
and muscle with trace levels in the lung and pancreas
(Fig. 1C). The wide distribution of NDAP mRNA in the brain
and other tissues suggested a general function.
In culture, the mRNA expression level of NDAP transiently
peaked in day 4 neurons, and then signiﬁcantly declined on
day 7 (90% of day 4 levels; P < 0.05) and day 10 (87% of
day 4 levels; P < 0.05) (Fig. 2A), which seemed to follow the
functional maturation course of neurons in culture (days 4–
7) [5]. Such changes in NDAP mRNA levels were also found
in primary cultures of cerebral cortical astrocytes, which
peaked at week 2 (P < 0.05) and signiﬁcantly declined after-
wards (week 3–4 levels were 80% of week 2 levels;
P < 0.05) (Fig. 2B). Developmental expression was also de-
tected in vivo, in embryonic mouse brain by Northern blot.
Namely, an increase early in development from E14 to 18, fol-
lowed by a later decline from E18 to P9 (unpublished data).
The high levels of NDAP in younger, and lower levels in older,
neurons and astrocytes indicated that a fall in NDAP expres-
sion might allow neural cells to enter further phases of diﬀer-
entiation and maturation.
To investigate a role in neuronal development, we examined
NDAP gene expression in neuronal cultures under treatment
of factors known to aﬀect neuronal development: NT-3,
GDNF, insulin, and high potassium levels. GDNF and insulin
are involved in stimulating developing neurons and preserving
responsiveness in mature neurons [10,11], while potassium reg-
ulates the electrical activity of neurons and the growth and
branching processes of axons [12]. NT-3 levels and its eﬀects
are precisely temporally regulated during development, and
various functions have been proposed for its presence very
early in neurogenesis [13]. NDAP expression under treatments
of GDNF, insulin, or high potassium concentration did not
show any diﬀerence from that of the untreated control
(Fig. 3). However, NT-3 treated cultures did not exhibit the de-Fig. 2. NDAP mRNA expression proﬁles. (A) NDAP mRNA expression
increased signiﬁcantly in the ﬁrst 4 days and then declined signiﬁcantly aft
diﬀerent ages. The NDAP level peaked at week 2 and then declined signiﬁc
control; #, P < 0.05 as compared to day 4 neurons or week 2 astrocytes; n,cline in NDAP levels typically seen in neurons from days 4 to 7
(Fig. 3); NDAP mRNA levels remained high in these cultures
throughout the observation period (10 days). This reduction in
NDAP gene downregulation after NT-3 treatment suggests
regulation of NDAP expression by NT-3.
Neurotrophins exert two major eﬀects: promoting neuronal
survival and inducing apoptosis, through regulation of the
expression of downstream genes [2,3]. To elucidate the role
of neurotrophins in regulating NDAP expression, we treated
day 5 neurons which have decreasing NDAP levels, with
NT-3, BDNF or NGF for 48 h, measured the NDAP mRNA
levels, and compared them with those of the untreated control
(at day 7). NT-3 and BDNF both precluded the decline of
NDAP in day 7 neurons, but only the NT-3 eﬀect was statisti-
cally signiﬁcant (Fig. 4A). Thus NT-3, and possibly BDNF,
might exert an upregulatory eﬀect or prevent downregulation
of NDAP expression during early neuron development. In
contrast, NGF appeared to slightly enhance the decline of
NDAP levels in neurons from days 5 to 7. To conﬁrm this
downregulatory eﬀect, day 3 neurons were treated with NGF
for 24 h. Day 3 neurons in cultures under normal developmen-
tal conditions exhibit increasing expression of NDAP
(Fig. 2A). The ability of NGF to downregulate gene expression
of NDAP in these neurons was statistically signiﬁcant, thus
conﬁrming its downregulatory eﬀect (Fig. 4B).
NT-3, BDNF and NGF are three distinct members of the
developmentally timed neurotrophins, whose expression coin-
cides with the onset of neurogenesis and axon elongation
[14,15]. During development, they all begin to be expressed
simultaneously but the dynamics of their expression vary
greatly, and their sequential appearance is critical for neuronal
survival and maturation [13,16,17]. NT-3 is the major neuro-
trophin expressed at high levels in the early embryonic period,
and especially in more immature regions. Its mRNA levels de-
crease while those of BDNF, initially very low, gradually in-
crease. NGF displays comparatively constant mRNA levels,
which increase as early axons reach their targets. Previous ﬁnd-
ings have suggested that neuronal survival responses to thisin primary cultures of neurons of diﬀerent ages. The level of NDAP
erwards. n = 3. (B) NDAP levels in primary cultures of astrocytes of
antly afterwards. n = 3. D, day; wk, week; *, P < 0.05 as compared to
number of independent experiments.
Fig. 3. NDAP levels in neurons grown with NT-3, GDNF, insulin or high potassium. NDAP mRNA levels were measured on days 2, 4, 7, and 10.
Only NT-3 prevented the decline of NDAP from day 4 to day 10. D, day.
Fig. 4. A: Neurons in day 5 cultures were treated with NGF, BDNF and NT-3 for 48 h. NDAP mRNA levels were measured on day 7. Both NT-3
and BDNF treated neurons had higher NDAP levels, but only that of NT-3 was statistically signiﬁcant. NGF treated neurons had apparently lower
NDAP levels compared with the controls, but this was not signiﬁcant. n = 3. (B) Neurons in day 3 cultures were treated with NGF for 24 h and the
NDAP level was measured on day 4. A signiﬁcantly lower level of NDAP was detected as compared to the untreated control. n = 3.
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[13,18,19]. The report by Paul and Davies [18] also indicated
that the survival response of cultured neurons to speciﬁc neu-
rotrophins is highly dependant on the embryonic stage at
which the cells are taken. Although in vitro systems might
not completely mimic the in vivo situation, our cultured neu-
rons prepared from E16 mice cerebra are immature on day 1
and begin to diﬀerentiate, extending neurites to be functionally
mature from days 4 to 7. NGF applied on day 3 was able to
cause premature downregulation of NDAP indicating that
the cultured neurons were NGF-responsive by this stage. Thus
BDNF and NT-3 might normally act to maintain NDAP levels
before this stage has been reached.
To investigate how high levels of NDAP might aﬀect cells,
we over-expressed NDAP in astrocytes and observed their
changes under confocal and ﬂuorescent microscopes. Astro-
cytes in primary cultures were used for their higher transfec-
tion eﬃciency and greater tolerance towards the transfection
process than neurons [20]. EGFP transfected astrocytes
showed intact and normal morphology (Fig. 5A); whereas
NDAP-EGFP transfected astrocytes displayed a shrunken cell
body with fewer processes (Fig. 5A). Newly expressed ﬂuores-cent NDAP-EGFP was conﬁned to the cytoplasm; but gradu-
ally aggregated into membranous structures, possibly those
associated with the endoplasmic reticulum (unpublished data).
Nuclear condensation was observed in these NDAP-EGFP
transfected astrocytes (Fig. 5B). These shrunken astrocytes
with condensed nuclei eventually detached from the culture
dish and could be positively immunostained for cleaved cas-
pase-3 indicating apoptosis (unpublished data). Similar trans-
fection experiments were performed in the HEK293 cell line.
Signiﬁcantly shrunken cell bodies indicating prominent apop-
tosis (Fig. 5C, arrowheads) were detected in detached cells col-
lected from HEK293 cell line culture 48 h after transfection
with NDAP-EGFP. A death rate of over 40% was found
for NDAP-EGFP transfected HEK293 cells compared with
10% for EGFP transfected cells (Fig. 5C).
During development, about half the neurons originally pres-
ent will undergo apoptosis with mechanisms remaining ob-
scure [1]. Neurotrophins are known to be involved in the
regulation of survival during development. The classical neu-
rotrophin hypothesis proposed that the survival of neurons
was determined by their access to survival factors [21]. How-
ever, this was modiﬁed after neurotrophins, including NT-3,
Fig. 5. (A) Astrocytes in 4-week-old cultures were transfected with NDAP-EGFP fusion protein. The transfected cultures were viewed under phase
contrast and ﬂuorescent microscopes after 24 h. EGFP transfected astrocytes (arrows) showed intact and normal astrocyte morphology with
ﬂuorescence evenly distributed in the cytoplasm (upper panels). NDAP-EGFP transfected astrocytes (arrowheads) showed a shrunken cell body with
less cell processes. NDAP was only detected in the cytoplasm, not in the nucleus, and appeared as green ﬂuorescence aggregated in membranous
structures. (B) Condensed nucleus located in an NDAP over-expressing astrocyte. (C) NDAP-EGFP transfected HEK293 cells. HEK293 cells were
transfected with EGFP and NDAP-EGFP, respectively. Because detachment occurred with NDAP-EGFP transfected cultures, cells in the medium
were collected by centrifugation and re-plated in poly-D-lysine coated dishes. PI staining was performed without ﬁxation to identify dead cells.
Signiﬁcantly shrunken cell bodies and higher cell death rate (40%) were detected in NDAP-EGFP transfected HEK293 cells. Arrowheads indicated
PI positive transfected cells. n = 5. Bar = 20 lm.
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tosis directly [2,3]. It is now thought that neuronal survival is
dependent on the ratio of survival to apoptosis signals from
diﬀerent neurotrophins.
During normal neuronal development, NDAP expression
naturally decreases, and our artiﬁcial maintenance of high
NDAP levels through over-expression led to apoptosis. As a
downstream eﬀecter of neurotrophins, NDAP might be in-
volved in neurotrophin regulated apoptosis during develop-
ment. The initial rise in NDAP mRNA levels in the mouse
embryonic brain at days E14-18 (unpublished data), coincides
with the time when massive apoptosis (50–70%) is seen in theembryonic cerebral cortex in vivo [22]. This correlation may
be signiﬁcant in the light of our ﬁndings.
The facts that NT-3 and BDNF both appeared to upregulate
or preclude the decline of NDAP expression and that NGF
could enhance this decline, are consistent with a hypothesis
that high NDAP expression in more mature developing neu-
rons should be downregulated by NGF to allow entry into fur-
ther stages of development, such as diﬀerentiation and
maturation. Neurons maintaining a high level of NDAP would
not enter maturation but would die through apoptosis. Thus
neurotrophins, NT-3 and BDNF, might oppose rather than
mediate neuronal survival and the continued high levels of
1728 H.L. Li et al. / FEBS Letters 580 (2006) 1723–1728NDAP in response to NT-3 and BDNF might represent a pro-
cess by which developing neurons are eliminated from an inap-
propriate environment. Thus, NDAP, a novel neurotrophin
regulated protein, is a new element and potential checkpoint
for survival or apoptosis control during development.
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